Skip to main content
OpenTrials
Completed

NCT Number: NCT05447117

Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Central Serous Retinopathy With Subretinal Fluid

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minia University Hospital

Minya, Minya Governorate, 61111, Egypt

About this study

This prospective study included 42 eyes of 42 patients with acute CSCR treated with IRIDEX™ IQ 532 nm GSML. The study was conducted at Minia University Hospital and Genaidy Ophthalmology Center, Minia, Egypt between October 2019 and May 2022. All patients were subjected to a complete ophthalmological examination, fluorescein angiography (FA) and optical coherence tomography (OCT) at baseline and each follow-up visit 1, 3 and 18 months after laser treatment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute CSCR

Exclusion criteria

  • chronic CSCR Previously treated case of Acute CSCR

Treatment and study plan

Micropulse laser

Procedure

532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).

Primary outcomes

  1. change in visual acuity

    Time frame: 18 months

    resolution of subretinal fluid

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Subthreshold Micropulse 532 nm Green Laser Treatment of Acute Central Serous Chorioretinopathy: 18-month Results

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Jul 7, 2022
Registry last updated
Sep 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.